Request Trial

Marisa Woutersen

Key details

Marisa Woutersen is a senior reporter for Life Sciences Intellectual Property Review and World IP Review. She largely covers intellectual property developments across the global life sciences sector, including pharmaceuticals, biotechnology, medtech, AI, M&A and regulation.

Since joining Newton Media in 2023, Marisa has reported across a wide range of topics, from the rise of generative AI and its impact on the creative industries to the crossover between intellectual property and sport, including issues affecting athletes, as well as global pharmaceutical disputes, vaccine technology, access to medicines and life sciences M&A.

She has reported live from court and regularly travels to international conferences, where she interviews lawyers, business leaders and other key industry figures.

Marisa holds a Master’s in International Law and a BA in Politics and International Relations from the University of Sussex, and is currently completing her NCTJ Diploma in Journalism.

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine search
Total results: 456

Articles by Marisa Woutersen

Skinny labels, big stakes: SCOTUS lines up the case of the year
Americas
Skinny labels, big stakes: SCOTUS lines up the case of the year
The court’s review of a high-profile dispute could offer clarity on a grey area for pharma companies and generic drug makers, but also prompt fresh questions.   21 January 2026
Chinese biotech strikes billion dollar deal in nextgen cancer race
Asia
Chinese biotech strikes billion dollar deal in nextgen cancer race
Magic Circle and major US firm among dealmakers who worked on the licensing agreement for a bispecific antibody candidate, marking another significant outbound licensing deal from China’s biopharma sector.   20 January 2026
$5.4bn medtech leader fails to bury a rival's patent
Americas
$5.4bn medtech leader fails to bury a rival's patent
An Israeli medical device company’s lawsuit claims Edwards knowingly infringed its heart-valve patent, raising new risks as the giant pursues growth beyond its core market.   19 January 2026
Careers
Senior four-partner team leaves A&O Shearman
The team, known for pharmaceutical and biotechnology patent litigation—including Hatch-Waxman and BPCIA disputes—as well as trade secret and licensing matters, joins a rival US firm.   16 January 2026
Americas
Speciality pharma firm stumbles on bid to enforce Belbuca ruling
A court has blocked the patent owner's latest attempt to stop a generic rival as it weighs the right way to challenge a new product.   15 January 2026
Careers
Senior USPTO solicitor steps into private practice
A high-profile departure from the USPTO sees a senior appellate expert move into private practice as demand increases in the firm's life sciences IP practice.   14 January 2026
Careers
Goodwin targets transatlantic patent work with London hire
The US firm has recruited a European patent attorney with three decades of experience to build its patent prosecution offering across the continent.   14 January 2026
Europe
Bayer secures key Denmark ruling as Xarelto faces expiry pressure
As the drug moves deeper into its post-exclusivity phase, a Nordic decision highlights the value of secondary patents, presumption of validity, and interim relief when a drug's core patents expire.   13 January 2026
Americas
From migraine drugs to COVID vaccine spats, US lawsuits pile up
A busy week in US courts saw major pharma companies and biotech firms move to protect key therapies and research tools, with new lawsuits over migraine and cancer drug generics, and alleged misuse of COVID-19 vaccine tech.   9 January 2026
Americas
Insulin pump rivals face off in major trade secrets dispute hearing
Important questions about when companies must act on suspicions of theft and whether damages can stack with injunctions were raised in a dispute that has already sent ripples across med tech.   8 January 2026

Not finding what you're looking for, please try resetting your applied search and filters,
or try the full site search.